Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation by Regué, L, Minichiello, L, Avruch, J, Dai, N

IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1 by Dai, N, Ji, F, Wright, J, Minichiello, L, Sadreyev, R, Avruch, J

IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1 by Dai, N, Ji, F, Wright, J, Minichiello, L, Sadreyev, R, Avruch, J

IMP2 Increases Mouse Skeletal Muscle Mass and Voluntary Activity by Enhancing Autocrine Insulin-Like Growth Factor 2 Production and Optimizing Muscle Metabolism by Regué, L, Ji, F, Flicker, D, Kramer, D, Pierce, W, Davidoff, T, Widrick, J, Houstis, N, Minichiello, L, Dai, N, Avruch, J

Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk by Greenwald, W, Chiou, J, Yan, J, Qiu, Y, Dai, N, Wang, A, Nariai, N, Aylward, A, Han, J, Kadakia, N, Regue, L, Okino, M, Drees, F, Kramer, D, Vinckier, N, Minichiello, L, Gorkin, D, Avruch, J, Frazer, K, Sander, M, Ren, B, Gaulton, K